Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026)
Azenta (AZTA) recorded quarterly Liabilities and Shareholders Equity of $1.9 billion in Q1 2026, down 8.22% quarter-over-quarter from $2.1 billion in Q4 2025, and down 6.4% on a YoY basis from $2.0 billion in Q1 2025.
Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Azenta's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 6.4% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $8.1 billion (down 5.22% YoY), while the FY2025 annual figure was $2.1 billion, changed N/A from the prior year.
- Liabilities and Shareholders Equity was $1.9 billion for Q1 2026 at Azenta, down from $2.1 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.2 billion in Q1 2022 to a low of $1.9 billion in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 149.93% in 2022, then dropped 27.67% in 2024.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.3 billion in 2022, then dropped by 14.22% to $2.8 billion in 2023, then decreased by 27.67% to $2.0 billion in 2024, then increased by 1.55% to $2.1 billion in 2025, then decreased by 8.22% to $1.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $1.9 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | 1.90 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Bn |
| Dec 31, 2025 | 2.07 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.02 Bn |
| Mar 31, 2025 | 2.03 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2.10 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 2.56 Bn |
| Dec 31, 2023 | 2.82 Bn |
| Sep 30, 2023 | 2.89 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.25 Bn |
| Dec 31, 2022 | 3.29 Bn |
| Sep 30, 2022 | 3.72 Bn |
| Jun 30, 2022 | 3.72 Bn |
| Mar 31, 2022 | 4.16 Bn |
| Dec 31, 2021 | 1.85 Bn |
| Sep 30, 2021 | 1.82 Bn |
| Jun 30, 2021 | 1.76 Bn |